Tesamorelin
Tesamorelin is a growth hormone-releasing hormone (GHRH) analogue currently being researched for its interaction with growth hormone signaling, metabolic regulation, and body composition pathways. Research has focused on its potential role in stimulating endogenous growth hormone release and influencing fat metabolism-related processes.
Studies have also explored Tesamorelin’s relationship with IGF-1 signaling, visceral fat research, and metabolic function.
Common Research Uses
- Growth hormone signaling
- Visceral fat and body composition
- Recovery and cellular regeneration
- Metabolic and IGF-1 pathway analysis
Typical Research Dosing
Subcutaneous Protocol (10 mg + 3 mL BAC = ~3.33 mg/mL)
| Phase | Daily Dose (mg) | Units per Injection |
|---|---|---|
| Week 1 | 1 mg once daily | 30 units |
| Weeks 2+ | 2 mg once daily | 60 units |
Based on reconstitution of 10 mg with 3 mL bacteriostatic water (~3.33 mg/mL).
Reconstitution Steps
- Prep clean: Wash hands, use a clean surface, and gather supplies.
- Sanitize: Alcohol swab vial stoppers and allow to air-dry.
- Add diluent slowly: Inject bacteriostatic water down the vial wall to reduce foaming.
- Mix gently: Gently swirl or roll until fully dissolved. Do not shake.
- Label: Write compound name, date, and concentration (mg/mL).
- Store appropriately: Store according to supplier guidance and maintain sterile technique.
Educational reference only
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
- Allow the peptide to reach room temperature before injection.
- Clean the vial stopper and injection site with alcohol and allow to fully dry.
- Pinch a small skinfold and insert the needle at a 45–90° angle into subcutaneous tissue.
- Do not aspirate for subcutaneous injections; inject slowly and steadily.
- Rotate injection sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
- Inject slowly to help minimize any stinging sensation.
This information is provided for educational reference only and reflects general clinical best practices.
Supplies Needed (Auto Calculator)
Inventory planning tool. Choose presets or enter your own values.
Notes: Syringes = (weeks × 7 × injections/day). Swabs = (syringes × swabs/injection). BAC = (vials × mL per vial). Bottles/boxes are rounded up.
Recommended Source
We recommend MADDOG Peps for high-purity Tesamorelin (10 mg).
- High-purity lots with manufacturer-issued third-party COAs available upon request for transparency and quality reference.
- Consistent handling practices aligned with quality control standards.
- Reliable fulfillment, careful packaging, and fast UPS shipping to help maintain product integrity.
How It Works
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), a naturally occurring hormone involved in regulating growth hormone secretion from the pituitary gland. Research suggests it works by stimulating GHRH receptors in the pituitary, leading to increased endogenous growth hormone release and downstream IGF-1 activity.
Studies have explored Tesamorelin’s interaction with pathways associated with fat metabolism, particularly visceral adipose tissue regulation. Researchers have shown interest in its potential influence on lipid metabolism, body composition signaling, and metabolic efficiency through growth hormone-related mechanisms.
At the cellular and systemic level, Tesamorelin has been studied for its role in growth hormone and IGF-1 signaling cascades involved in tissue maintenance, recovery processes, and nutrient metabolism. Additional research has examined its relationship with mitochondrial activity, protein synthesis pathways, and metabolic regulation.
Unlike direct growth hormone administration, Tesamorelin is being researched for its ability to stimulate the body’s natural growth hormone release pathways through GHRH receptor activation.
Commonly Reported Side Effects
- Fatigue
- Nausea
- Mild Headache
- Injection site reactions
- Water retention or bloating
- Temporary flushing sensations
These effects are based on commonly reported research observations and may vary by individual.